CASE STUDY – IPM
Achieve Regulatory Approval
When the International Partnership for Microbicides (IPM) approached the regulators for approval of their HIV prevention ring, they requested additional data on uterine contractility. Find out how our studies in fresh human uterine tissue helped IPM gain approval.
CASE STUDY – Amgen
Avoid Species Differences
Read our case study on Amgen's publication, which highlights the useful comparisons that can be made between matched tissues from preclinical species and humans.
CASE STUDY – Roche
Eliminate Clinical Adverse Effects
Adverse effects may go undetected during preclinical safety assessments and only become apparent during clinical trials. In most cases, such adverse effects in humans were not observed in animal models.
CASE STUDY – Bionorica
Evaluating the Spasmolytic Effects of BNO 1095
REPROCELL supported Bionorica in advancing BNO 1095, a plant-based treatment for primary dysmenorrhea, through human tissue studies demonstrating its spasmolytic effects.
